Feel The Pulse Of China's Api Industry: Market Rebound Still Worries
11 15 ~ 17, the beautiful coastal city of Qingdao
, China ushered in the end of the year APIs ending event - the 57th China International Pharmaceutical / intermediate / packaging / equipment Autumn Fair (APICHINA ). The Fair has two bright spots, one Sinopharm Reed Exhibition and the World Pharmaceutical Industry (IN Juan TERPHEX) cooperation, set up at the show in the world pharmaceutical industry development zone (INTERPHEXCHINA), so APICHINA brand image and international influence force to further improve; Second Forum of China and India, two big countries APIs unfolding relationship between the theme of competing domestic and foreign experts look to the future of Chinese API industry and international trade trends.
No doubt, as the world's chemical raw production centers to Asia, China has become one of the world's raw material drug production centers, APICHINA not only became the world to understand China API window, is seen as a barometer of market changes . While the bulk drug industry, with production scale expanding influence in the international market, increasing by international markets, market change is also increasingly complex. The APICHINA, the embodiment of this feature very clearly.
Situation for the better In APICHINA the Summit, the China Chemical Pharmaceutical Industry Association data show that the pharmaceutical industry this year, although the decline in the overall situation, but the first half of the twenty-four major categories of Chemical Raw Material export situation still maintained a good momentum, yield complete 240,000 tons, the supply of 115,000 tons exported complete, up 13%, increase over last year rose by 5.6 percentage points. Anti-infective drugs which block production of raw materials increased by 8.98%, the supply of exports increased by 16.42%; antipyretic analgesic drugs production increased by 3.84%, exports increased by 29.04%.
Anti-infective drugs production and exports have maintained rapid growth, the first half of macrolides and cephalosporins increased significantly, the growth rate is relatively large penicillin, tetracyclines, fluoroquinolones and production of all anti-virus products picked up. It is worth mentioning that the majority of our products, bulk drugs cephalosporins with the introduction of domestic production technology and improved and they have to export from import-based export growth mainly by the expansion of the export countries and regions. To ceftriaxone, for example, exporting countries increased from 31 last year, 42 this year, new countries mainly in Asia; cefotaxime export more than last year in 16 countries and regions, increasing the range of 69%. And this corresponds, in the pharmaceutical industry association to track the first half of the 15 priority species imported cephalosporins, in the first half only imported 10, and 5 varieties of which imports fell.
In addition, the Customs export data show that the first three quarters this year, Chinese API exports 5.489 billion U.S. dollars total, of which chemical raw, Shenghua Yao raw materials, plant extracts 52% of total exports, 54%. Organic acids, amino acids, vitamins, antibiotics and antipyretics and analgesics are the largest of the five types of chemical raw exports, exports accounted for two-thirds. Antibiotics, the largest proportion of export value bulk drugs, accounting for 21%.
Health Network Principal Investigator Hui-Fang Wu, this year the first three quarters of cefaclor antibiotic, ethambutol, Ceftizoxime, cefpiramide, vancomycin, high-purity vitamin vitamins, vitamin K1, K2 , vitamin B2, immune inhibitor of cyclosporine, tacrolimus, carotene, lycopene, astaxanthin, lutein, plant extracts from soy isoflavones, proanthocyanidins, and A Kaposi sugar, Simvastatin, coenzyme Q10, lipoic acid and other varieties, outstanding performance in the market, pharmaceutical raw materials into high-profile species. At the same time, this large quantity of bulk drug price in the export of the highest reputation of penicillin industrial salt in September the prices have increased 8% year on year, in December last year rose 32% when the downturn, growth in exports around 1,000 tons. Caffeine, and metronidazole for the D products are widely used in the international market, intermediate prices rose, driving the export volume and price movements well.
Hui-Fang Wu said that due to heavy volume price of staple cultivar Yang phenomenon, this year was a lot of pressure on raw material drug companies some flexibility.
Feel The Pulse Of China's Api Industry: Market Rebound Still Worries
By: qoqo
Types Of Foreclosure Scams Where Is The Future Of Property Market? As vantagens de usar um software de Email Marketing para sua empresa ou Negocio Is Traffic Siphon A Scam-Know To Find Out What's Coming Your Way! Look For Better Results When Your Marketing Is Orchestrated Bank Marketing Basics Is There A Dubli Scam Or Just Crazy Talk Trading Currency Strategies: Profit As A Forex Currency Trader Through These Techniques Roswell: Technology + Marketing Two Get Far more Traffic With Viral Marketing From The "if You Are" To See The Four Principles Of Implantable Marketing Why Not Break The Bamboo Flooring Industry, The Pain In The Domestic Market Overall Paper Stock Fundamentals Warming Beat The Market